CONUS MEDULLARIS SYNDROME

CONUS MEDULLARIS SYNDROME was reported 65 times

CONUS MEDULLARIS SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Oxytocic [EPC] 1 0.0003
1 Radiographic Contrast Agent [EPC] 3 0.0001
2 Amide Local Anesthetic [EPC] 7 0.0001
3 Prostaglandin E1 Analog [EPC] 1 0.0001
4 Ester Local Anesthetic [EPC] 3 0.0001
5 Dihydropyridine Calcium Channel Blocker [EPC] 18 0.0001
6 Non-Standardized Chemical Allergen [EPC] 3 0.0000
7 Peroxisome Proliferator Receptor alpha Agonist [EPC] 2 0.0000
8 Alkylating Drug [EPC] 8 0.0000
9 Antiarrhythmic [EPC] 3 0.0000
10 CD20-directed Cytolytic Antibody [EPC] 9 0.0000
11 Topoisomerase Inhibitor [EPC] 2 0.0000
12 General Anesthetic [EPC] 1 0.0000
13 beta-Adrenergic Blocker [EPC] 7 0.0000
14 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
15 Folate Analog Metabolic Inhibitor [EPC] 8 0.0000
16 Corticosteroid [EPC] 16 0.0000
17 Integrin Receptor Antagonist [EPC] 1 0.0000
18 Mood Stabilizer [EPC] 2 0.0000
19 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
20 Atypical Antipsychotic [EPC] 4 0.0000
21 Platelet Aggregation Inhibitor [EPC] 5 0.0000
22 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
23 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
24 Opioid Agonist [EPC] 2 0.0000
25 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
26 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
27 Expectorant [EPC] 1 0.0000
28 Anti-epileptic Agent [EPC] 1 0.0000
29 Benzodiazepine [EPC] 3 0.0000
30 Nonsteroidal Anti-inflammatory Drug [EPC] 5 0.0000
31 Platinum-based Drug [EPC] 1 0.0000
32 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
33 Tumor Necrosis Factor Blocker [EPC] 1 0.0000